Integrated DNA Technologies has launched two next-gen sequencing-based disease panels.

The xGen Inherited Disease Panel was designed in collaboration with Emory Genetics Laboratory and targets all the exons of genes in the Human Gene Mutation Database. The xGen Pan-Cancer Panel is based on the findings of the Cancer Genome Atlas and targets coding regions in 127 genes implicated in 12 tumor types.

Both panels feature xGen Lockdown Probes, which are 120-mer oligonucleotides with a 5' biotin modification.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.